Moxicloprid 100 400 mg / 4 mL Solution is a Health Canada–registered veterinary drug (DIN 02523671) held by Modern Veterinary Therapeutics LLC, containing Imidacloprid. Health Canada lists its status as Dormant (status date 28 Jul 2026). Nexara Health has matched 16 registrations of Imidacloprid across 4 other regulated markets.
Health Canada registration
| DIN | 02523671 |
|---|---|
| Brand name | Moxicloprid 100 |
| Active ingredient | Imidacloprid |
| Strength | 400 mg / 4 mL |
| Dosage form | Solution |
| Route | Topical |
| Company | Modern Veterinary Therapeutics LLC |
| Status | Dormant — 28 Jul 2026 |
| Class | Veterinary |
| ATC | |
| AHFS | |
| Regulator record | Health Canada DPD entry · Product monograph |
Status and company history
Changes Health Canada has recorded for this DIN, as observed by Nexara Health's weekly DPD comparison.
| Date | Field | From | To |
|---|---|---|---|
| 2026-09-03 | Status | Marketed | Dormant |
| 2026-09-03 | Status | Marketed | Dormant |
Imidacloprid registered in other markets
16 registrations of the same molecule in 4 national registries outside Canada. Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| Denmark | Advantage Vet. til hund | Elanco Animal Health GmbH | 100 mg/ml | kutanopløsning | MRP | Laegemiddelstyrelsen |
| Denmark | Advantage Vet. til hund | Elanco Animal Health GmbH | 100 mg/ml | kutanopløsning | MRP | Laegemiddelstyrelsen |
| Denmark | Advantage Vet. til hunde (10-25 kg) | Elanco Animal Health GmbH | 100 mg/ml | kutanopløsning | MRP | Laegemiddelstyrelsen |
| Denmark | Advantage Vet. til hunde (4-10 kg) | Elanco Animal Health GmbH | 100 mg/ml | kutanopløsning | MRP | Laegemiddelstyrelsen |
| Denmark | Advantage Vet. til kat | Elanco Animal Health GmbH | 100 mg/ml | kutanopløsning | MRP | Laegemiddelstyrelsen |
| Denmark | Advantage Vet. til katte (4 kg og derover) | Elanco Animal Health GmbH | 100 mg/ml | kutanopløsning | MRP | Laegemiddelstyrelsen |
| Hong Kong | Advantage 100 Soln 100mg/mL (Vet) | Unipet House Company Limited | Registered | DH Drug Office | ||
| Hong Kong | Advantage 250 Soln 250mg/2.5ml (Vet) | Unipet House Company Limited | Registered | DH Drug Office | ||
| Hong Kong | Advantage 40 For Cats Solution 40mg/0.4ml (Vet) | Unipet House Company Limited | Registered | DH Drug Office | ||
| Hong Kong | Advantage 40 Soln 40mg/0.4ml (Vet) | Unipet House Company Limited | Registered | DH Drug Office | ||
| Hong Kong | Advantage 400 Soln 400mg/4ml (Vet) | Unipet House Company Limited | Registered | DH Drug Office | ||
| Hong Kong | Advantage 80 For Cats Solution 80mg/0.8ml (Vet) | Unipet House Company Limited | Registered | DH Drug Office | ||
| Poland | Advantage 40 mg roztwór do nakrapiania dla kotów | Elanco Animal Health GmbH | 100 mg/ml | Roztwór do nakrapiania | Bezterminowe | URPL RPL |
| Poland | Advantage 80 mg roztwór do nakrapiania dla kotów | Elanco Animal Health GmbH | 100 mg/ml | Roztwór do nakrapiania | Bezterminowe | URPL RPL |
| United States | Imidacloprid | Jiangsu Willing Bio-Tech Co., Ltd. | Powder | FDA NDC | ||
| United States | Imidacloprid | Jiangsu Tianhe Pharmaceutical Co., Ltd. | Powder | FDA NDC |
See every manufacturer of Imidacloprid worldwide →
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Moxicloprid 100 (DIN 02523671) marketed in Canada?
No. Health Canada lists DIN 02523671 as Dormant as of 28 Jul 2026.
Who holds the Canadian licence for this product?
Modern Veterinary Therapeutics LLC is the company of record in the Health Canada Drug Product Database.
Is Imidacloprid registered outside Canada?
Yes — Nexara Health has matched 16 registrations in 4 other markets (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 02523671, status date 2026-07-28; national medicine registries: DH Drug Office, FDA NDC, Laegemiddelstyrelsen, URPL RPL. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 02523671, status date 2026-07-28; national medicine registries: DH Drug Office, FDA NDC, Laegemiddelstyrelsen, URPL RPL.
Health Canada Drug Product Database (DPD), DIN 02523671, status date 2026-07-28; national medicine registries: DH Drug Office, FDA NDC, Laegemiddelstyrelsen, URPL RPL. Last reviewed 2026-09-17. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.